Non-invasive panel tests for gastrointestinal motility monitoring within the MARS-500 Project
To develop an integrated approach for monitoring gastrointestinal motility and inflammation state suitable for application in long-term spaceflights. Breath tests based on the oral administration of ¹³C-labeled or hydrogen-producing substrates followed by the detection of their metabolites (¹³CO₂ or...
Saved in:
Published in | World journal of gastroenterology : WJG Vol. 19; no. 14; pp. 2208 - 2216 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
United States
Baishideng Publishing Group Co., Limited
2013
|
Subjects | |
Online Access | Get full text |
ISSN | 1007-9327 2219-2840 2219-2840 |
DOI | 10.3748/wjg.v19.i14.2208 |
Cover
Abstract | To develop an integrated approach for monitoring gastrointestinal motility and inflammation state suitable for application in long-term spaceflights.
Breath tests based on the oral administration of ¹³C-labeled or hydrogen-producing substrates followed by the detection of their metabolites (¹³CO₂ or H₂) in breath were used to measure gastrointestinal motility parameters during the 520-d spaceflight ground simulation within the MARS-500 Project. In particular, the gastric emptying rates of solid and liquid contents were evaluated by ¹³C-octanoic acid and ¹³C-acetate breath tests, respectively, whereas the orocecal transit time was assessed by an inulin H₂-breath test, which was performed simultaneously with the ¹³C-octanoic acid breath test. A ready-to-eat, standardized pre-packaged muffin containing 100 mg of ¹³C-octanoic acid was used in the ¹³C-octanoic acid breath test to avoid the extemporaneous preparation of solid meals. In addition, a cassette-type lateral flow immunoassay was employed to detect fecal calprotectin, a biomarker of intestinal inflammation. Because no items could be introduced into the simulator during the experiment, all materials and instrumentation required for test performance during the entire mission simulation had to be provided at the beginning of the experiment.
The experiments planned during the simulation of a manned flight to Mars could be successfully performed by the crewmembers without any external assistance. No evident alterations (i.e., increasing or decreasing trends) in the gastric emptying rates were detected using the ¹³C-breath tests during the mission simulation, as the gastric emptying half-times were in the range of those reported for healthy subjects. In contrast to the ¹³C-breath tests, the results of the inulin H₂-breath test were difficult to interpret because of the high variability of the H₂ concentration in the breath samples, even within the same subject. This variability suggested that the H₂-breath test was strongly affected by external factors, which may have been related to the diet of the crewmembers or to environmental conditions (e.g., the accumulation of hydrogen in the simulator microenvironment). At least in closed microenvironments such as the MARS-500 simulator, ¹³C-breath tests should therefore be preferred to H₂-breath tests. Finally, the fecal calprotectin test showed significant alterations during the mission simulation: all of the crewmembers were negative for the test at the beginning of the simulation but showed various degrees of positivity in at least one of the subsequent tests, thus indicating the onset of an intestinal inflammation.
Breath tests, especially those ¹³C-based, proved suitable for monitoring gastrointestinal motility in the 520-d isolation experiment within MARS-500 project and can be applied in long-term spaceflights. |
---|---|
AbstractList | To develop an integrated approach for monitoring gastrointestinal motility and inflammation state suitable for application in long-term spaceflights.AIMTo develop an integrated approach for monitoring gastrointestinal motility and inflammation state suitable for application in long-term spaceflights.Breath tests based on the oral administration of ¹³C-labeled or hydrogen-producing substrates followed by the detection of their metabolites (¹³CO₂ or H₂) in breath were used to measure gastrointestinal motility parameters during the 520-d spaceflight ground simulation within the MARS-500 Project. In particular, the gastric emptying rates of solid and liquid contents were evaluated by ¹³C-octanoic acid and ¹³C-acetate breath tests, respectively, whereas the orocecal transit time was assessed by an inulin H₂-breath test, which was performed simultaneously with the ¹³C-octanoic acid breath test. A ready-to-eat, standardized pre-packaged muffin containing 100 mg of ¹³C-octanoic acid was used in the ¹³C-octanoic acid breath test to avoid the extemporaneous preparation of solid meals. In addition, a cassette-type lateral flow immunoassay was employed to detect fecal calprotectin, a biomarker of intestinal inflammation. Because no items could be introduced into the simulator during the experiment, all materials and instrumentation required for test performance during the entire mission simulation had to be provided at the beginning of the experiment.METHODSBreath tests based on the oral administration of ¹³C-labeled or hydrogen-producing substrates followed by the detection of their metabolites (¹³CO₂ or H₂) in breath were used to measure gastrointestinal motility parameters during the 520-d spaceflight ground simulation within the MARS-500 Project. In particular, the gastric emptying rates of solid and liquid contents were evaluated by ¹³C-octanoic acid and ¹³C-acetate breath tests, respectively, whereas the orocecal transit time was assessed by an inulin H₂-breath test, which was performed simultaneously with the ¹³C-octanoic acid breath test. A ready-to-eat, standardized pre-packaged muffin containing 100 mg of ¹³C-octanoic acid was used in the ¹³C-octanoic acid breath test to avoid the extemporaneous preparation of solid meals. In addition, a cassette-type lateral flow immunoassay was employed to detect fecal calprotectin, a biomarker of intestinal inflammation. Because no items could be introduced into the simulator during the experiment, all materials and instrumentation required for test performance during the entire mission simulation had to be provided at the beginning of the experiment.The experiments planned during the simulation of a manned flight to Mars could be successfully performed by the crewmembers without any external assistance. No evident alterations (i.e., increasing or decreasing trends) in the gastric emptying rates were detected using the ¹³C-breath tests during the mission simulation, as the gastric emptying half-times were in the range of those reported for healthy subjects. In contrast to the ¹³C-breath tests, the results of the inulin H₂-breath test were difficult to interpret because of the high variability of the H₂ concentration in the breath samples, even within the same subject. This variability suggested that the H₂-breath test was strongly affected by external factors, which may have been related to the diet of the crewmembers or to environmental conditions (e.g., the accumulation of hydrogen in the simulator microenvironment). At least in closed microenvironments such as the MARS-500 simulator, ¹³C-breath tests should therefore be preferred to H₂-breath tests. Finally, the fecal calprotectin test showed significant alterations during the mission simulation: all of the crewmembers were negative for the test at the beginning of the simulation but showed various degrees of positivity in at least one of the subsequent tests, thus indicating the onset of an intestinal inflammation.RESULTSThe experiments planned during the simulation of a manned flight to Mars could be successfully performed by the crewmembers without any external assistance. No evident alterations (i.e., increasing or decreasing trends) in the gastric emptying rates were detected using the ¹³C-breath tests during the mission simulation, as the gastric emptying half-times were in the range of those reported for healthy subjects. In contrast to the ¹³C-breath tests, the results of the inulin H₂-breath test were difficult to interpret because of the high variability of the H₂ concentration in the breath samples, even within the same subject. This variability suggested that the H₂-breath test was strongly affected by external factors, which may have been related to the diet of the crewmembers or to environmental conditions (e.g., the accumulation of hydrogen in the simulator microenvironment). At least in closed microenvironments such as the MARS-500 simulator, ¹³C-breath tests should therefore be preferred to H₂-breath tests. Finally, the fecal calprotectin test showed significant alterations during the mission simulation: all of the crewmembers were negative for the test at the beginning of the simulation but showed various degrees of positivity in at least one of the subsequent tests, thus indicating the onset of an intestinal inflammation.Breath tests, especially those ¹³C-based, proved suitable for monitoring gastrointestinal motility in the 520-d isolation experiment within MARS-500 project and can be applied in long-term spaceflights.CONCLUSIONBreath tests, especially those ¹³C-based, proved suitable for monitoring gastrointestinal motility in the 520-d isolation experiment within MARS-500 project and can be applied in long-term spaceflights. To develop an integrated approach for monitoring gastrointestinal motility and inflammation state suitable for application in long-term spaceflights. Breath tests based on the oral administration of ¹³C-labeled or hydrogen-producing substrates followed by the detection of their metabolites (¹³CO₂ or H₂) in breath were used to measure gastrointestinal motility parameters during the 520-d spaceflight ground simulation within the MARS-500 Project. In particular, the gastric emptying rates of solid and liquid contents were evaluated by ¹³C-octanoic acid and ¹³C-acetate breath tests, respectively, whereas the orocecal transit time was assessed by an inulin H₂-breath test, which was performed simultaneously with the ¹³C-octanoic acid breath test. A ready-to-eat, standardized pre-packaged muffin containing 100 mg of ¹³C-octanoic acid was used in the ¹³C-octanoic acid breath test to avoid the extemporaneous preparation of solid meals. In addition, a cassette-type lateral flow immunoassay was employed to detect fecal calprotectin, a biomarker of intestinal inflammation. Because no items could be introduced into the simulator during the experiment, all materials and instrumentation required for test performance during the entire mission simulation had to be provided at the beginning of the experiment. The experiments planned during the simulation of a manned flight to Mars could be successfully performed by the crewmembers without any external assistance. No evident alterations (i.e., increasing or decreasing trends) in the gastric emptying rates were detected using the ¹³C-breath tests during the mission simulation, as the gastric emptying half-times were in the range of those reported for healthy subjects. In contrast to the ¹³C-breath tests, the results of the inulin H₂-breath test were difficult to interpret because of the high variability of the H₂ concentration in the breath samples, even within the same subject. This variability suggested that the H₂-breath test was strongly affected by external factors, which may have been related to the diet of the crewmembers or to environmental conditions (e.g., the accumulation of hydrogen in the simulator microenvironment). At least in closed microenvironments such as the MARS-500 simulator, ¹³C-breath tests should therefore be preferred to H₂-breath tests. Finally, the fecal calprotectin test showed significant alterations during the mission simulation: all of the crewmembers were negative for the test at the beginning of the simulation but showed various degrees of positivity in at least one of the subsequent tests, thus indicating the onset of an intestinal inflammation. Breath tests, especially those ¹³C-based, proved suitable for monitoring gastrointestinal motility in the 520-d isolation experiment within MARS-500 project and can be applied in long-term spaceflights. AIM: To develop an integrated approach for monitoring gastrointestinal motility and inflammation state suitable for application in long-term spaceflights. METHODS: Breath tests based on the oral administration of 13 C-labeled or hydrogen-producing substrates followed by the detection of their metabolites ( 13 CO 2 or H 2 ) in breath were used to measure gastrointestinal motility parameters during the 520-d spaceflight ground simulation within the MARS-500 Project. In particular, the gastric emptying rates of solid and liquid contents were evaluated by 13 C-octanoic acid and 13 C-acetate breath tests, respectively, whereas the orocecal transit time was assessed by an inulin H 2 -breath test, which was performed simultaneously with the 13 C-octanoic acid breath test. A ready-to-eat, standardized pre-packaged muffin containing 100 mg of 13 C-octanoic acid was used in the 13 C-octanoic acid breath test to avoid the extemporaneous preparation of solid meals. In addition, a cassette-type lateral flow immunoassay was employed to detect fecal calprotectin, a biomarker of intestinal inflammation. Because no items could be introduced into the simulator during the experiment, all materials and instrumentation required for test performance during the entire mission simulation had to be provided at the beginning of the experiment. RESULTS: The experiments planned during the simulation of a manned flight to Mars could be successfully performed by the crewmembers without any external assistance. No evident alterations ( i.e ., increasing or decreasing trends) in the gastric emptying rates were detected using the 13 C-breath tests during the mission simulation, as the gastric emptying half-times were in the range of those reported for healthy subjects. In contrast to the 13 C-breath tests, the results of the inulin H 2 -breath test were difficult to interpret because of the high variability of the H 2 concentration in the breath samples, even within the same subject. This variability suggested that the H 2 -breath test was strongly affected by external factors, which may have been related to the diet of the crewmembers or to environmental conditions ( e.g ., the accumulation of hydrogen in the simulator microenvironment). At least in closed microenvironments such as the MARS-500 simulator, 13 C-breath tests should therefore be preferred to H 2 -breath tests. Finally, the fecal calprotectin test showed significant alterations during the mission simulation: all of the crewmembers were negative for the test at the beginning of the simulation but showed various degrees of positivity in at least one of the subsequent tests, thus indicating the onset of an intestinal inflammation. CONCLUSION: Breath tests, especially those 13 C-based, proved suitable for monitoring gastrointestinal motility in the 520-d isolation experiment within MARS-500 project and can be applied in long-term spaceflights. |
Author | Roda, Aldo |
Author_xml | – sequence: 1 givenname: Aldo surname: Roda fullname: Roda, Aldo |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23599647$$D View this record in MEDLINE/PubMed |
BookMark | eNp1UUtPGzEQtioQBMq9J-RjL5uO7X3YFySEgFbiJQpHZDkbbzLRxg62E8S_r1c8BEjVHDwafw97vj2y5byzhPxgMBZNKX89LWbjDVNjZOWYc5DfyIhzpgouS9giIwbQFErwZpfsxbgA4EJUfIfsclEpVZfNiDxceVeg25iIG0tXxtmeJhtTpJ0PdGZiCh7dMEFnerr0CXtMz7lxmHxAN6NPmOboaJpbenl8-7eoAOhN8Avbpu9kuzN9tAev5z65Pzu9O_ldXFyf_zk5vihaoepUVJ1QbcdaybisJjVnwk4EkzBlipsSSsmBiTKDzFQ1uTolpLXTmlWsBFMJsU-OXnRX68nSTlvrUjC9XgVcmvCsvUH9-cbhXM_8RouaN1JWWeDnq0Dwj-v8W73E2Nq-zwvx66iZEAwUKDl4HX70ejd522kGwAugDT7GYLt3CAM9xKZzbDrHpnNseogtU-ovlBaTSeiH12L_f-I_bWCezg |
CitedBy_id | crossref_primary_10_1016_j_bios_2018_03_062 crossref_primary_10_1016_j_csbj_2021_03_040 crossref_primary_10_1186_s40168_017_0256_8 crossref_primary_10_1007_s40618_018_0861_9 crossref_primary_10_1111_1541_4337_12633 crossref_primary_10_1113_EP091527 crossref_primary_10_1038_s41598_021_82044_3 crossref_primary_10_1186_s40168_017_0345_8 crossref_primary_10_1089_omi_2015_0181 |
ContentType | Journal Article |
Copyright | 2013 Baishideng Publishing Group Co., Limited. All rights reserved. 2013 |
Copyright_xml | – notice: 2013 Baishideng Publishing Group Co., Limited. All rights reserved. 2013 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.3748/wjg.v19.i14.2208 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2219-2840 |
EndPage | 2216 |
ExternalDocumentID | PMC3627885 23599647 10_3748_wjg_v19_i14_2208 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 123 29R 2WC 36B 53G 5VR 8WL 92F 92I AAKDD AAYXX ACGFO AENEX AFUIB ALMA_UNASSIGNED_HOLDINGS CCEZO CHBEP CIEJG CITATION CS3 CW9 DIK DU5 E3Z EBS EJD F5P FA0 FRP GX1 HYE OK1 P2P RNS RPM TCJ TGQ TR2 WFFXF XSB CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c396t-5f39cf1c81285b6213eb3180d192a404820134f39ad97979f938eed615140a533 |
ISSN | 1007-9327 2219-2840 |
IngestDate | Thu Aug 21 14:09:25 EDT 2025 Fri Jul 11 06:13:29 EDT 2025 Mon Jul 21 06:04:29 EDT 2025 Thu Apr 24 23:07:15 EDT 2025 Tue Jul 01 03:21:59 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 14 |
Keywords | Breath test Gastrointestinal motility Gastrointestinal inflammation Spaceflight Stress |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c396t-5f39cf1c81285b6213eb3180d192a404820134f39ad97979f938eed615140a533 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Author contributions: Roda A designed the research; Mirasoli M, Simoni P and Festi D developed experimental protocols and materials; Afonin B and Vasilyeva G supervised the experiments during the simulation of a manned mission to Mars; Guardigli M analyzed the data; Roda A, Mirasoli M and Guardigli M wrote the paper; Roda A and Afonin B revised the final version of the paper. Correspondence to: Aldo Roda, Professor, Department of Chemistry “G. Ciamician”, University of Bologna-Alma Mater Studiorum, Via Selmi 2, Bologna 40126, Italy. aldo.roda@unibo.it Telephone: +39-51-343398 Fax: +39-51-343398 |
OpenAccessLink | https://doi.org/10.3748/wjg.v19.i14.2208 |
PMID | 23599647 |
PQID | 1331090983 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3627885 proquest_miscellaneous_1331090983 pubmed_primary_23599647 crossref_primary_10_3748_wjg_v19_i14_2208 crossref_citationtrail_10_3748_wjg_v19_i14_2208 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-00-00 |
PublicationDateYYYYMMDD | 2013-01-01 |
PublicationDate_xml | – year: 2013 text: 2013-00-00 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | World journal of gastroenterology : WJG |
PublicationTitleAlternate | World J Gastroenterol |
PublicationYear | 2013 |
Publisher | Baishideng Publishing Group Co., Limited |
Publisher_xml | – name: Baishideng Publishing Group Co., Limited |
References | 10492364 - J Nucl Med. 1999 Sep;40(9):1451-5 9448183 - Am J Gastroenterol. 1998 Jan;93(1):92-8 7801958 - Am J Gastroenterol. 1995 Jan;90(1):93-8 17021896 - Exp Brain Res. 2006 Nov;175(3):377-99 11908886 - Aviat Space Environ Med. 2002 Mar;73(3):206-10 15209531 - Physiol Res. 2004;53(3):245-53 10427653 - Z Gastroenterol. 1999 Jun;37(6):477-81 19505663 - Best Pract Res Clin Gastroenterol. 2009;23(3):337-52 9097998 - Gastroenterology. 1997 Apr;112(4):1155-62 17100982 - Am J Gastroenterol. 2007 Jan;102(1):132-6 12806605 - Gastroenterology. 2003 Jun;124(7):1728-37 15286087 - J Clin Pharmacol. 2004 Aug;44(8):837-53 18350835 - Aviakosm Ekolog Med. 2007 Nov-Dec;41(6):37-43 16534878 - World J Gastroenterol. 2006 Feb 28;12(8):1243-8 15644347 - Ann N Y Acad Sci. 2004 Nov;1027:74-84 12145798 - Gastroenterology. 2002 Aug;123(2):450-60 16474100 - Gut. 2006 Mar;55(3):297-303 22314561 - J Physiol Pharmacol. 2011 Dec;62(6):591-9 22423496 - Aviakosm Ekolog Med. 2011 Nov-Dec;45(6):52-7 12361787 - Nutrition. 2002 Oct;18(10):913-20 14510746 - Aliment Pharmacol Ther. 2003 Oct 1;18(7):721-9 20116352 - Dig Liver Dis. 2010 Aug;42(8):549-53 9675662 - Ital J Gastroenterol Hepatol. 1998 Apr;30(2):211-7 15852539 - J Br Interplanet Soc. 2005 Mar-Apr;58(3-4):117-30 8237860 - Am J Clin Nutr. 1993 Nov;58(5):583-8 19004188 - Adv Clin Chem. 2008;46:87-130 650346 - J Pediatr. 1978 Jul;93(1):62-6 18537637 - Curr Mol Med. 2008 Jun;8(4):299-312 7698571 - Gastroenterology. 1995 Apr;108(4):1048-55 18597588 - Clin Chem Lab Med. 2008;46(9):1275-80 1761729 - J Clin Pharmacol. 1991 Oct;31(10):968-73 17652042 - Dig Liver Dis. 2007 Sep;39(9):795-805 7995201 - Dig Dis Sci. 1994 Dec;39(12 Suppl):107S-109S 8083399 - J Clin Pharmacol. 1994 Jun;34(6):671-6 17727672 - Eur J Clin Invest. 2007 Oct;37(10):802-7 15735075 - J Nutr. 2005 Mar;135(3):437-43 19943520 - Aviakosm Ekolog Med. 2009 Jul-Aug;43(4):39-42 8500721 - Gastroenterology. 1993 Jun;104(6):1640-7 |
References_xml | – reference: 17100982 - Am J Gastroenterol. 2007 Jan;102(1):132-6 – reference: 17727672 - Eur J Clin Invest. 2007 Oct;37(10):802-7 – reference: 14510746 - Aliment Pharmacol Ther. 2003 Oct 1;18(7):721-9 – reference: 18537637 - Curr Mol Med. 2008 Jun;8(4):299-312 – reference: 11908886 - Aviat Space Environ Med. 2002 Mar;73(3):206-10 – reference: 20116352 - Dig Liver Dis. 2010 Aug;42(8):549-53 – reference: 10492364 - J Nucl Med. 1999 Sep;40(9):1451-5 – reference: 12145798 - Gastroenterology. 2002 Aug;123(2):450-60 – reference: 19004188 - Adv Clin Chem. 2008;46:87-130 – reference: 9097998 - Gastroenterology. 1997 Apr;112(4):1155-62 – reference: 15209531 - Physiol Res. 2004;53(3):245-53 – reference: 17652042 - Dig Liver Dis. 2007 Sep;39(9):795-805 – reference: 15286087 - J Clin Pharmacol. 2004 Aug;44(8):837-53 – reference: 7801958 - Am J Gastroenterol. 1995 Jan;90(1):93-8 – reference: 12361787 - Nutrition. 2002 Oct;18(10):913-20 – reference: 8237860 - Am J Clin Nutr. 1993 Nov;58(5):583-8 – reference: 7995201 - Dig Dis Sci. 1994 Dec;39(12 Suppl):107S-109S – reference: 12806605 - Gastroenterology. 2003 Jun;124(7):1728-37 – reference: 16534878 - World J Gastroenterol. 2006 Feb 28;12(8):1243-8 – reference: 650346 - J Pediatr. 1978 Jul;93(1):62-6 – reference: 15735075 - J Nutr. 2005 Mar;135(3):437-43 – reference: 19505663 - Best Pract Res Clin Gastroenterol. 2009;23(3):337-52 – reference: 22314561 - J Physiol Pharmacol. 2011 Dec;62(6):591-9 – reference: 1761729 - J Clin Pharmacol. 1991 Oct;31(10):968-73 – reference: 19943520 - Aviakosm Ekolog Med. 2009 Jul-Aug;43(4):39-42 – reference: 16474100 - Gut. 2006 Mar;55(3):297-303 – reference: 18350835 - Aviakosm Ekolog Med. 2007 Nov-Dec;41(6):37-43 – reference: 9675662 - Ital J Gastroenterol Hepatol. 1998 Apr;30(2):211-7 – reference: 17021896 - Exp Brain Res. 2006 Nov;175(3):377-99 – reference: 9448183 - Am J Gastroenterol. 1998 Jan;93(1):92-8 – reference: 15852539 - J Br Interplanet Soc. 2005 Mar-Apr;58(3-4):117-30 – reference: 18597588 - Clin Chem Lab Med. 2008;46(9):1275-80 – reference: 10427653 - Z Gastroenterol. 1999 Jun;37(6):477-81 – reference: 8083399 - J Clin Pharmacol. 1994 Jun;34(6):671-6 – reference: 15644347 - Ann N Y Acad Sci. 2004 Nov;1027:74-84 – reference: 8500721 - Gastroenterology. 1993 Jun;104(6):1640-7 – reference: 22423496 - Aviakosm Ekolog Med. 2011 Nov-Dec;45(6):52-7 – reference: 7698571 - Gastroenterology. 1995 Apr;108(4):1048-55 |
SSID | ssj0023352 |
Score | 2.0983913 |
Snippet | To develop an integrated approach for monitoring gastrointestinal motility and inflammation state suitable for application in long-term spaceflights.
Breath... To develop an integrated approach for monitoring gastrointestinal motility and inflammation state suitable for application in long-term spaceflights.AIMTo... AIM: To develop an integrated approach for monitoring gastrointestinal motility and inflammation state suitable for application in long-term spaceflights.... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 2208 |
SubjectTerms | Acetates - metabolism Adult Astronauts Breath Tests - methods Brief Caprylates - metabolism Carbon Dioxide - metabolism Carbon Isotopes - metabolism Feces - chemistry Gastric Emptying Gastrointestinal Transit Humans Hydrogen - metabolism Inflammation - immunology Inflammation - physiopathology Inflammation Mediators - metabolism Inulin - metabolism Leukocyte L1 Antigen Complex - metabolism Male Predictive Value of Tests Space Flight Time Factors Weightlessness Simulation |
Title | Non-invasive panel tests for gastrointestinal motility monitoring within the MARS-500 Project |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23599647 https://www.proquest.com/docview/1331090983 https://pubmed.ncbi.nlm.nih.gov/PMC3627885 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZb97KXsbFbtm5osJdRnFqWbEuPZbSU0mbQJiwvw_iiZB6pPVy3hf76nSNZrpOW0Y2ACbIsm3M-HX26fSLkMwdaGxRB6DEd5Z5Qi9TLoJX2dAGtvWAyDY2W3skkOpyJo3k4v53BN7tL2myc39y7r-R_vApp4FfcJfsPnu0LhQT4D_6FK3gYrg_y8aSuvLK6Ss0SdKjWerUDzLE1Egs7y_SibWqUg4BajJwTl90Z0n1u6nHjhmG7lY4ne6dnXuj7uHcAB2eGtNUuuRmoTNjCUc-zsSJOOLLw_ag_qOu0LuyA7aqoe5-WTQr2KLstQn17YFG6dDegkp73z5yV-LGW6rZNeVOmw2EKu7_UxrEAgqIHraCdftH3pLlArIaAE8OwGhjxhzvxHrVzwEnXv5bjK6bGJRNjl3VdWnvyLTmYHR8n0_359DF5EsQxC93QTtc7x81neBKh-zI7p41v2N0sf53D3OmYbK6vHRCW6XPyrOtp0D0Lmxfkka5ekh9DyFADGWogQwEydBMy1EGG3kKGWshQgAx1kKEdZF6R2cH-9Ouh152w4eVcRa0XLrjKFywHlifDLAoY1xkEeb8A3p8KCO7oSQGZ0kLF8FsoLoFUIQsWfgo9hddkq6or_ZbQTMkc-F6mFz4XWuosZ7lScSozyTWLoxHZdTZL8k5-Hk9BWSXQDUUrJ2DlBKycgJUTtPKIfOmf-G2lV_6S95NzQwLxESe9wIL15UXCOGrf-kryEXlj3dKXFnAUJxLxiMRrDuszoPb6-p2q_Gk02IH3xVKG7x7w3vfkaWDOUMFxu22y1TaX-gMw2Tb7aBD4B0CYo_I |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Non-invasive+panel+tests+for+gastrointestinal+motility+monitoring+within+the+MARS-500+Project&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Roda%2C+Aldo&rft.au=Mirasoli%2C+Mara&rft.au=Guardigli%2C+Massimo&rft.au=Simoni%2C+Patrizia&rft.date=2013&rft.issn=2219-2840&rft.eissn=2219-2840&rft.volume=19&rft.issue=14&rft.spage=2208&rft_id=info:doi/10.3748%2Fwjg.v19.i14.2208&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1007-9327&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1007-9327&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1007-9327&client=summon |